Newsroom

News

EU-OPENSCREEN Director General, Wolfgang Fecke, will continue to support the work of the Executive Board for the life sciences cluster, Franciska de Jong, Executive Director, CLARIN ERIC, for the…

Read more

The European Commission has launched a manifesto to maximise the accessibility of research results in the fight against COVID-19. The manifesto provides guiding principles for beneficiaries of EU…

Read more

We are proud to welcome the Translational Medicinal and Biological Chemistry Laboratory headed by Prof. Ana Martinez, at the Margarita Salas Center for Biological Research (Centro de Investigaciones…

Read more

In FBDD low-molecular-weight fragments (<250 Da) are screened using structural biology and biophysical techniques to identify hits, which commonly have lower binding affinities (in the range of…

Read more

After the inclusion of EU-OPENSCREEN in the Romanian Roadmap for Research Infrastructures, we are pleased about another major success in Romania: Our partner the Coriolan Dragulescu Institute of…

Read more

We congratulate PT-OPENSCREEN for being included in the 2020 Portuguese Roadmap of Research Infrastructures. PT-OPENSCREEN unites the major Portuguese research centres in the areas of chemistry and…

Read more

Our annual report for 2019 is now available

EU-OPENSCREEN News

The report showcases an eventful and exciting year on our path of becoming the leading European research infrastructure for chemical biology. Denmark joined us as a new member country, we successfully…

Read more

EU-OPENSCREEN is part of "Zukunftsorte Berlin"

EU-OPENSCREEN News

EU-OPENSCREEN is proud to be part of “Zukunftsorte” Berlin an association of leading science locations in Berlin, Berlin’s eleven places of future innovation. The mission is to bring Berlin’s…

Read more

Watch the new video on how working with European Life Science Research Infrastructures can advance your research project. EU-OPENSCREEN is part of the European Research Infrastructure landscape and…

Read more

Fundación MEDINA, Almirall, S.A. (ALM) and the University Carlos III Madrid (UC3M) have launched a project to find new treatments for recessive dystrophic epidermolysis bullosa and other genetic…

Read more